Hearing Implants - Medical Devices Pipeline Assessment, 2018

Hearing implants are electronic devices implanted into the ear of a deaf or hard to hear person. GlobalData's Medical Devices sector report, “Hearing implants - Medical Devices Pipeline Assessment, 2018" provides comprehensive information about the Hearing implants pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Hearing implants Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Hearing implants under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Hearing implants pipeline products.

Review of Recent Developments in the segment / industry

The Hearing implants Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Hearing implants under development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

  • 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2009 and forecast to 2023
  • 4,500+ industry-leading analysis and procedure reports covering growing sectors, market trends, investment opportunities and competitive landscape
  • 56,000+ medical equipment company profiles
  • 4,300+ company profiles of medical equipment manufacturers in China and India
  • 2,000+ company profiles of medical equipment manufacturers in Japan
  • 825+ companies’ revenue splits and market shares
  • 1,900+ quarterly and annual medical equipment company financials
  • 940+ medical equipment company SWOTs
  • 21,500+ pipeline product profiles
  • 34,500+ marketed product profiles
  • 36,000+ clinical trials
  • 36,500+ trial investigators
  • 5,400+ reports on companies with products in development
  • 33,000+ deals in the medical equipment industry
  • 1,300+ surgical and diagnostic procedures by therapy area
  • 50+ key healthcare indicators by country

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Hearing implants under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Hearing implants and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Hearing implants under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies mentioned

Advanced Bionics LLC

Auritec Pharmaceuticals Inc

Ceragenix Pharmaceuticals, Inc. (Inactive)

Cochlear Ltd

Hannover Medical School

Huntington Medical Research Institutes

Labyrinth Devices

Nasseo, Inc.

Northwestern University ...

Advanced Bionics LLC

Auritec Pharmaceuticals Inc

Ceragenix Pharmaceuticals, Inc. (Inactive)

Cochlear Ltd

Hannover Medical School

Huntington Medical Research Institutes

Labyrinth Devices

Nasseo, Inc.

Northwestern University

Oticon Medical AB

OtoKinetics Inc

Ototronix, LLC

Sonova Holding AG

SpecialtyCare Inc

Tel Aviv Sourasky Medical Center

Trinity College Dublin

University of Florida

University of Michigan

University of Michigan Pediatric Device Consortium

University of Nottingham

University of Oklahoma

University of South Florida

University of Utah

University of Wisconsin Madison

Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 Hearing Implants Overview 7

3 Products ...

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 Hearing Implants Overview 7

3 Products under Development 8

3.1 Hearing Implants - Pipeline Products by Stage of Development 8

3.2 Hearing Implants - Pipeline Products by Segment 9

3.3 Hearing Implants - Pipeline Products by Territory 10

3.4 Hearing Implants - Pipeline Products by Regulatory Path 11

3.5 Hearing Implants - Pipeline Products by Estimated Approval Date 12

3.6 Hearing Implants - Ongoing Clinical Trials 13

4 Hearing Implants - Pipeline Products under Development by Companies 14

4.1 Hearing Implants Companies - Pipeline Products by Stage of Development 14

4.2 Hearing Implants - Pipeline Products by Stage of Development 16

5 Hearing Implants Companies and Product Overview 17

5.1 Advanced Bionics LLC Company Overview 17

5.1.1 Advanced Bionics LLC Pipeline Products & Ongoing Clinical Trials Overview 17

5.2 Auritec Pharmaceuticals Inc Company Overview 18

5.2.1 Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 18

5.3 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 19

5.3.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 19

5.4 Cochlear Ltd Company Overview 20

5.4.1 Cochlear Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

5.5 Hannover Medical School Company Overview 22

5.5.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 22

5.6 Huntington Medical Research Institutes Company Overview 23

5.6.1 Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview 23

5.7 Labyrinth Devices Company Overview 24

5.7.1 Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview 24

5.8 Nasseo, Inc. Company Overview 27

5.8.1 Nasseo, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27

5.9 Northwestern University Company Overview 28

5.9.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 28

5.10 Oticon Medical AB Company Overview 29

5.10.1 Oticon Medical AB Pipeline Products & Ongoing Clinical Trials Overview 29

5.11 OtoKinetics Inc Company Overview 33

5.11.1 OtoKinetics Inc Pipeline Products & Ongoing Clinical Trials Overview 33

5.12 Ototronix, LLC Company Overview 35

5.12.1 Ototronix, LLC Pipeline Products & Ongoing Clinical Trials Overview 35

5.13 Sonova Holding AG Company Overview 36

5.13.1 Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview 36

5.14 SpecialtyCare Inc Company Overview 38

5.14.1 SpecialtyCare Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.15 Tel Aviv Sourasky Medical Center Company Overview 39

5.15.1 Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 39

5.16 Trinity College Dublin Company Overview 40

5.16.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 40

5.17 University of Florida Company Overview 41

5.17.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 41

5.18 University of Michigan Company Overview 42

5.18.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 42

5.19 University of Michigan Pediatric Device Consortium Company Overview 43

5.19.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 43

5.20 University of Nottingham Company Overview 44

5.20.1 University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 44

5.21 University of Oklahoma Company Overview 45

5.21.1 University of Oklahoma Pipeline Products & Ongoing Clinical Trials Overview 45

5.22 University of South Florida Company Overview 46

5.22.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 46

5.23 University of Utah Company Overview 47

5.23.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 47

5.24 University of Wisconsin Madison Company Overview 48

5.24.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 48

6 Hearing Implants- Recent Developments 49

6.1 Feb 27, 2018: Intersect ENT Reports Fourth Quarter and Full Year 2017 Results 49

6.2 Feb 27, 2018: Cochlear and The Royal Victorian Eye and Ear Hospital Open the Geelong Cochlear Care Centre - a first for Regional 50

6.3 Feb 21, 2018: Canadian initiative designed to improve hearing goes global 51

6.4 Feb 19, 2018: Elos Medtech - Year- end report for the period 1 January to 31 December, 2017 52

6.5 Feb 15, 2018: Elos Medtech builds up a strong platform within Dental Implant Systems 52

6.6 Feb 07, 2018: Double-digit growth in revenue and earnings – delivered on guidance 53

6.7 Feb 07, 2018: Knowles Reports Q4 & Full Year 2017 Financial Results and Provides Outlook for Q1 2018 54

6.8 Jan 22, 2018: CUHK and US Researchers Use Brain Scan to Predict Language Improvement after a Cochlear Implant in Deaf Children 55

6.9 Jan 08, 2018: Intersect ENT Reports Preliminary Q4 and Year 2017 Revenue 56

6.10 Dec 21, 2017: Advanced Bionics Sound Processors to Become Bluetooth Compatible With Any Cell Phone or TV, Based on Revolutionary New Chip Technology From Sonova 57

6.11 Dec 01, 2017: 3-D-Printed Prosthetic Implants Could Improve Treatment for Hearing Loss 58

6.12 Nov 27, 2017: Cochlear obtains FDA approval for first remote programming option for cochlear implants 59

6.13 Nov 14, 2017: Elos Medtech commits to the global orthopaedic market 60

6.14 Nov 13, 2017: First half results 2017/18: Sonova with strong growth across all businesses 60

6.15 Nov 02, 2017: Intersect ENT Reports Third Quarter 2017 Results 64

6.16 Oct 25, 2017: Elos Medtech: Interim report 1 January - 30 September, 2017 65

6.17 Oct 25, 2017: Knowles Reports Q3 2017 Financial Results and Provides Outlook for Q4 2017 66

6.18 Oct 03, 2017: Cochlear Introduces the World’s First Made for iPhone Cochlear Implant Sound Processor in the United Kingdom 66

6.19 Sep 01, 2017: Sonova appoints Arnd Kaldowski as new CEO and successor of Lukas Braunschweiler 68

6.20 Aug 25, 2017: Elos Medtech Interim Report January 1 - June 30, 2017 68

6.21 Aug 17, 2017: Cochlear Announces Financial Results for year Ended June 2017 70

6.22 Aug 03, 2017: Knowles Appoints Dr. Cheryl Shavers To Board of Directors 77

6.23 Aug 01, 2017: Intersect ENT Reports Second Quarter 2017 Results 78

6.24 Jul 31, 2017: Cochlear: Chief Executive Officer & President Transition Timeline Announced 79

6.25 Jul 26, 2017: Cochlear introduces the world’s first Made for iPhone cochlear implant sound processor 80

6.26 Jul 26, 2017: Knowles Reports Q2 2017 Financial Results and Provides Outlook for Q3 2017 81

6.27 Jul 20, 2017: Teresa L. Kline Joins Intersect ENT’s Board of Directors 82

6.28 Jul 13, 2017: Sonova announces change in the Management Board 83

6.29 Jun 29, 2017: Sonova announces change in the Management Board in Corporate HRM and Communications 83

6.30 May 16, 2017: Sonova reports substantial acceleration and strong fiscal year 84

6.31 May 02, 2017: Intersect ENT Reports First Quarter 2017 Results 90

6.32 Apr 26, 2017: Knowles reports Q1 2017 financial results and provides outlook for Q2 2017 91

6.33 Apr 26, 2017: Elos Medtech Interim report, 1 January - 31 March, 2017 91

6.34 Mar 10, 2017: Managing Director at Elos Medtech Tianjin steps down 92

7 Appendix 94

7.1 Methodology 94

7.2 About GlobalData 97

7.3 Contact Us 97

7.4 Disclaimer 97

List of Tables

Table 1: Hearing Implants - Pipeline Products by Stage of Development 8

Table 2: Hearing Implants - Pipeline Products by Segment 9

Table 3: Hearing ...

Table 1: Hearing Implants - Pipeline Products by Stage of Development 8

Table 2: Hearing Implants - Pipeline Products by Segment 9

Table 3: Hearing Implants - Pipeline Products by Territory 10

Table 4: Hearing Implants - Pipeline Products by Regulatory Path 11

Table 5: Hearing Implants - Pipeline Products by Estimated Approval Date 12

Table 6: Hearing Implants - Ongoing Clinical Trials 13

Table 7: Hearing Implants Companies - Pipeline Products by Stage of Development 14

Table 8: Hearing Implants - Pipeline Products by Stage of Development 16

Table 11: Hires Fidelity 120 Pediatrics - Product Description 17

Table 12: Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 18

Table 15: Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 19

Table 18: Cochlear Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

Table 21: Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 22

Table 24: Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview 23

Table 27: Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview 24

Table 30: Labyrinth Devices - Ongoing Clinical Trials Overview 25

Table 31: MVI Vestibular Implant System - First-in-human Early Feasibility Study of Safety, Tolerability and Efficacy for a Multichannel Vestibular Implant in Individuals with Bilateral Severe-to-profound Loss of Vestibular Sensation 26

Table 32: Nasseo, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27

Table 35: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 28

Table 38: Oticon Medical AB Pipeline Products & Ongoing Clinical Trials Overview 29

Table 43: Oticon Medical AB - Ongoing Clinical Trials Overview 31

Table 44: Neuro Zti Implant - The Neuro Zti Cochlear Implant System Efficacy and Safety in Adults 32

Table 45: Neuro Zti Implant - Voice Guard Processing Evaluation in a Cohort of Subjects Implanted with the Neuro Cochlear Implant System 32

Table 46: OtoKinetics Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Table 51: Ototronix, LLC Pipeline Products & Ongoing Clinical Trials Overview 35

Table 54: Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview 36

Table 59: SpecialtyCare Inc Pipeline Products & Ongoing Clinical Trials Overview 38

Table 62: Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 39

Table 65: Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 40

Table 68: University of Florida Pipeline Products & Ongoing Clinical Trials Overview 41

Table 71: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 42

Table 74: University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 43

Table 77: University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 44

Table 80: University of Oklahoma Pipeline Products & Ongoing Clinical Trials Overview 45

Table 83: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 46

Table 86: University of Utah Pipeline Products & Ongoing Clinical Trials Overview 47

Table 89: University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 48

Table 92: Glossary 95

List of Figures

Figure 1: Hearing Implants - Pipeline Products by Stage of Development 8

Figure 2: Hearing Implants - Pipeline Products by Segment 9

Figure 3: Hearing ...

Figure 1: Hearing Implants - Pipeline Products by Stage of Development 8

Figure 2: Hearing Implants - Pipeline Products by Segment 9

Figure 3: Hearing Implants - Pipeline Products by Territory 10

Figure 4: Hearing Implants - Pipeline Products by Regulatory Path 11

Figure 5: Hearing Implants - Pipeline Products by Estimated Approval Date 12

Figure 6: Hearing Implants - Ongoing Clinical Trials 13

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports